Next Article in Journal
Effects of Eating While Walking on Blood Glucose Concentrations
Open AccessArticle

The Diagnostic Value of Chromogranin A in Neuroendocrine Neoplasms is Potentiated by Clinical Factors and Inflammatory Markers

1
Department of Endocrinology, Diabetes and Metabolism, Hygeia Hospital, 15123 Athens, Greece
2
Endocrine and Metabolic Bone Disorders Unit, 2nd Department of Internal Medicine and Research Institute and Diabetes Center, Attikon University Hospital, 12462 Athens, Greece
3
School of Medicine, European University Cyprus (EUC), Nicosia 2404, Cyprus
4
Section of Neuroendocrine Tumors—3rd Department of Internal Medicine, National and Kapodistrian University of Athens, “Sotiria” Hospital, 11527 Athens, Greece
*
Author to whom correspondence should be addressed.
Endocrines 2020, 1(1), 1-12; https://doi.org/10.3390/endocrines1010001
Received: 11 February 2020 / Revised: 22 February 2020 / Accepted: 2 March 2020 / Published: 5 March 2020
Objective: Neuroendocrine neoplasms (NENs) are a heterogenous group of indolent tumors, with variable clinical behavior and steadily rising incidence. The aim of this study is to investigate the clinical and laboratory factors that contribute in predicting the aggressiveness and invasiveness of NENs. Special focus is given to clinical parameters that would enhance the diagnostic value of chromogranin A (CgA), via formalizing an integrated probability model, which would contribute to the timely and accurate identification of patients at high risk for metastatic disease at initial diagnosis. Designs and Methods: We identified a total of 93 patients with NENs, recruited at a specialized academic center in Athens, Greece. Anthropometric, clinical, laboratory, and pathological data were obtained from every patient before any therapeutic intervention. Results: Age over 50 years and male gender were accompanied by increased risk for metastases at the time of initial diagnosis. Additionally, when these parameters were combined with CgA levels, they were shown to enhance the predictive capacity of CgA. Different patient scenarios combining age, gender, and CgA levels are associated with different probabilities for metastatic disease, demonstrated schematically in a gradually escalating model, as age and CgA levels increase in both males and females. The lowest risk is observed in women aged <50 years old with CgA levels <200 ng/dl (6.5%), while the highest one is in males over 50 years old with CgA > 200 ng/dl (62.9%). Finally, it was shown that c-reactive protein (CRP) can predict disease extent at the time of diagnosis. Conclusions: CgA levels can not only be used as a direct predictor of tumor load in patients with NENs, but also, when interpolated with the effects of age and gender, cumulatively predict whether a NEN would be metastatic or not at the time of initial diagnosis, via a risk-escalating probability model. View Full-Text
Keywords: neuroendocrine neoplasms; chromogranin A; CRP; sex; age neuroendocrine neoplasms; chromogranin A; CRP; sex; age
Show Figures

Figure 1

MDPI and ACS Style

Papalou, O.; Peppa, M.; Kandaraki, E.A.; Diamanti-Kandarakis, E.; Nikou, G.C. The Diagnostic Value of Chromogranin A in Neuroendocrine Neoplasms is Potentiated by Clinical Factors and Inflammatory Markers. Endocrines 2020, 1, 1-12. https://doi.org/10.3390/endocrines1010001

AMA Style

Papalou O, Peppa M, Kandaraki EA, Diamanti-Kandarakis E, Nikou GC. The Diagnostic Value of Chromogranin A in Neuroendocrine Neoplasms is Potentiated by Clinical Factors and Inflammatory Markers. Endocrines. 2020; 1(1):1-12. https://doi.org/10.3390/endocrines1010001

Chicago/Turabian Style

Papalou, Olga; Peppa, Melpomeni; Kandaraki, Eleni A.; Diamanti-Kandarakis, Evanthia; Nikou, George C. 2020. "The Diagnostic Value of Chromogranin A in Neuroendocrine Neoplasms is Potentiated by Clinical Factors and Inflammatory Markers" Endocrines 1, no. 1: 1-12. https://doi.org/10.3390/endocrines1010001

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop